|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 48/00 | |
| C12N 15/13 | |||
| C12N 15/85 | |||
| C07K 16/28 | |||
| C07K 16/32 | |||
| A61K 39/395 |
| (11) | Number of the document | 2101823 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08701020.3 |
| Date of filing the European patent application | 2008-01-08 | |
| (97) | Date of publication of the European application | 2009-09-23 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/000081 |
| Date | 2008-01-08 |
| (87) | Number | WO 2008/083949 |
| Date | 2008-07-17 |
| (30) | Number | Date | Country code |
| 102007001370 | 2007-01-09 | DE |
| (72) |
HOERR, Ingmar, DE
PROBST, Jochen, DE
PASCOLO, Steve, CH
|
| (73) |
CureVac AG,
Paul-Ehrlich-Str. 15, 72076 Tübingen,
DE
|
| (54) | RNA-CODED ANTIBODY |
| RNA-CODED ANTIBODY |